170 related articles for article (PubMed ID: 37598923)
1. Astragaloside IV against Alzheimer's disease via microglia-mediated neuroinflammation using network pharmacology and experimental validation.
Bao M; Bade R; Liu H; Tsambaa B; Shao G; Borjigidai A; Cheng Y
Eur J Pharmacol; 2023 Oct; 957():175992. PubMed ID: 37598923
[TBL] [Abstract][Full Text] [Related]
2. Astragaloside IV Ameliorates Cognitive Impairment and Neuroinflammation in an Oligomeric Aβ Induced Alzheimer's Disease Mouse Model via Inhibition of Microglial Activation and NADPH Oxidase Expression.
Chen F; Yang D; Cheng XY; Yang H; Yang XH; Liu HT; Wang R; Zheng P; Yao Y; Li J
Biol Pharm Bull; 2021 Nov; 44(11):1688-1696. PubMed ID: 34433707
[TBL] [Abstract][Full Text] [Related]
3. Astragaloside IV ameliorates motor deficits and dopaminergic neuron degeneration via inhibiting neuroinflammation and oxidative stress in a Parkinson's disease mouse model.
Yang C; Mo Y; Xu E; Wen H; Wei R; Li S; Zheng J; Li W; Le B; Chen Y; Pan H; Huang S; Wang S; Wang Q
Int Immunopharmacol; 2019 Oct; 75():105651. PubMed ID: 31401385
[TBL] [Abstract][Full Text] [Related]
4. Depichering the Effects of Astragaloside IV on AD-Like Phenotypes: A Systematic and Experimental Investigation.
Wang X; Gao F; Xu W; Cao Y; Wang J; Zhu G
Oxid Med Cell Longev; 2021; 2021():1020614. PubMed ID: 34616501
[TBL] [Abstract][Full Text] [Related]
5. Anti-neuroinflammatory effect of Sophoraflavanone G from Sophora alopecuroides in LPS-activated BV2 microglia by MAPK, JAK/STAT and Nrf2/HO-1 signaling pathways.
Guo C; Yang L; Wan CX; Xia YZ; Zhang C; Chen MH; Wang ZD; Li ZR; Li XM; Geng YD; Kong LY
Phytomedicine; 2016 Dec; 23(13):1629-1637. PubMed ID: 27823627
[TBL] [Abstract][Full Text] [Related]
6. Protective Effect and Mechanism of Boswellic Acid and Myrrha Sesquiterpenes with Different Proportions of Compatibility on Neuroinflammation by LPS-Induced BV2 Cells Combined with Network Pharmacology.
Miao XD; Zheng LJ; Zhao ZZ; Su SL; Zhu Y; Guo JM; Shang EX; Qian DW; Duan JA
Molecules; 2019 Oct; 24(21):. PubMed ID: 31683684
[TBL] [Abstract][Full Text] [Related]
7. [Mechanism of Berberis atrocarpa anthocyanin against Alzheimer's disease based on network pharmacology and experimental verification].
Bao HY; Chen L; Yang Y; Li M; Li HM; Kang YY; Li JG
Zhongguo Zhong Yao Za Zhi; 2023 Feb; 48(3):778-788. PubMed ID: 36872242
[TBL] [Abstract][Full Text] [Related]
8. Xanthoceraside inhibits pro-inflammatory cytokine expression in Aβ25-35/IFN-γ-stimulated microglia through the TLR2 receptor, MyD88, nuclear factor-κB, and mitogen-activated protein kinase signaling pathways.
Qi Y; Zou LB; Wang LH; Jin G; Pan JJ; Chi TY; Ji XF
J Pharmacol Sci; 2013; 122(4):305-17. PubMed ID: 23966052
[TBL] [Abstract][Full Text] [Related]
9. Myricetin improves pathological changes in 3×Tg-AD mice by regulating the mitochondria-NLRP3 inflammasome-microglia channel by targeting P38 MAPK signaling pathway.
Liu P; Zhou Y; Shi J; Wang F; Yang X; Zheng X; Wang Y; He Y; Xie X; Pang X
Phytomedicine; 2023 Jul; 115():154801. PubMed ID: 37086707
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effects of Astragaloside IV for hair loss via inhibition of Fas/Fas L-mediated apoptotic signaling.
Kim MH; Kim SH; Yang WM
PLoS One; 2014; 9(3):e92984. PubMed ID: 24676213
[TBL] [Abstract][Full Text] [Related]
11. The extracts of Dracaena cochinchinensis stemwood suppress inflammatory response and phagocytosis in lipopolysaccharide-activated microglial cells.
Ospondpant D; Xia Y; Lai QWS; Yuen GK; Yang M; Chanthanam K; Dong TT; Tsim KWK
Phytomedicine; 2023 Sep; 118():154936. PubMed ID: 37385071
[TBL] [Abstract][Full Text] [Related]
12. NRF2/HO-1 activation via ERK pathway involved in the anti-neuroinflammatory effect of Astragaloside IV in LPS induced microglial cells.
Li C; Yang F; Liu F; Li D; Yang T
Neurosci Lett; 2018 Feb; 666():104-110. PubMed ID: 29273400
[TBL] [Abstract][Full Text] [Related]
13. Astragaloside IV, a Natural PPARγ Agonist, Reduces Aβ Production in Alzheimer's Disease Through Inhibition of BACE1.
Wang X; Wang Y; Hu JP; Yu S; Li BK; Cui Y; Ren L; Zhang LD
Mol Neurobiol; 2017 May; 54(4):2939-2949. PubMed ID: 27023226
[TBL] [Abstract][Full Text] [Related]
14. Microglial derived tumor necrosis factor-α drives Alzheimer's disease-related neuronal cell cycle events.
Bhaskar K; Maphis N; Xu G; Varvel NH; Kokiko-Cochran ON; Weick JP; Staugaitis SM; Cardona A; Ransohoff RM; Herrup K; Lamb BT
Neurobiol Dis; 2014 Feb; 62():273-85. PubMed ID: 24141019
[TBL] [Abstract][Full Text] [Related]
15. Protective Effect of Ferulic Acid on Lipopolysaccharide-Induced BV2 Microglia Inflammation via AMPK/mTOR Signaling Pathway.
Chen X; Zhou X; Cheng X; Lin L; Wang Q; Zhan R; Wu Q; Liu S
Molecules; 2023 Apr; 28(8):. PubMed ID: 37110714
[TBL] [Abstract][Full Text] [Related]
16. Astragaloside IV inhibits microglia activation via glucocorticoid receptor mediated signaling pathway.
Liu HS; Shi HL; Huang F; Peterson KE; Wu H; Lan YY; Zhang BB; He YX; Woods T; Du M; Wu XJ; Wang ZT
Sci Rep; 2016 Jan; 6():19137. PubMed ID: 26750705
[TBL] [Abstract][Full Text] [Related]
17. Piper sarmentosum Roxb. Root Extracts Confer Neuroprotection by Attenuating Beta Amyloid-Induced Pro-Inflammatory Cytokines Released from Microglial Cells.
Chan EWL; Yeo ETY; Wong KWL; See ML; Wong KY; Gan SY
Curr Alzheimer Res; 2019; 16(3):251-260. PubMed ID: 30819080
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Mechanism of Kai Xin San on Alzheimer's Disease Based on Network Pharmacology and Experimental Validation.
Wang K; Yang R; Chen TT; Qin MR; Wang P; Kong MW
Chin J Integr Med; 2023 May; 29(5):413-423. PubMed ID: 36474082
[TBL] [Abstract][Full Text] [Related]
19. Platycodigenin as Potential Drug Candidate for Alzheimer's Disease via Modulating Microglial Polarization and Neurite Regeneration.
Yang Z; Liu B; Yang LE; Zhang C
Molecules; 2019 Sep; 24(18):. PubMed ID: 31487775
[TBL] [Abstract][Full Text] [Related]
20. Network pharmacology analysis reveals neuroprotection of Gynostemma pentaphyllum (Thunb.) Makino in Alzheimer' disease.
Wang J; Shi J; Jia N; Sun Q
BMC Complement Med Ther; 2022 Mar; 22(1):57. PubMed ID: 35255879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
